Skip to content
  • Sunday, 26 July 2026
  • 1:44 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • BeOne Medicines Invests $300 Million to Expand Hopewell, New Jersey Manufacturing and Research Operations, Pushing Total US Investment Past $1 Billion
Pharmaceutical R&D

BeOne Medicines Invests $300 Million to Expand Hopewell, New Jersey Manufacturing and Research Operations, Pushing Total US Investment Past $1 Billion

Teuku Ryan Jul 24, 2026 0

BeOne Medicines is significantly bolstering its presence in the United States with a substantial $300 million investment earmarked for the…

Read More
Pharmaceutical R&D

AbbVie Invests $1.4 Billion in North Carolina for New Manufacturing Hub

Teuku Ryan Apr 23, 2026 0

AbbVie, a global biopharmaceutical leader, has announced a landmark $1.4 billion investment to establish its first manufacturing facility in North…

Read More
Pharmaceutical R&D

US Government Invests Heavily in Antibiotic Manufacturing to Combat Antimicrobial Resistance

Teuku Ryan Apr 10, 2026 0

The United States government, through the Biomedical Advanced Research and Development Authority (BARDA), has committed up to $482 million to…

Read More
Pharmaceutical R&D

Canada Invests C$79 Million in Aspect Biosystems to Accelerate Development of Bioengineered Cellular Medicines for Endocrine and Metabolic Diseases

Teuku Ryan Apr 6, 2026 0

Vancouver, BC – Aspect Biosystems, a pioneering company in the field of bioengineered cellular medicines, has received a significant C$79…

Read More
The Secret Lives of Beluga Whales Unveiled: DNA Study Reveals Remarkable Mating Strategies and Genetic Resilience in Bristol Bay PopulationEngineered Mie Voids in Bismuth Telluride Heterostructures Enable Enhanced Light-Matter Interactions in Atomically Thin SemiconductorsUS Life Sciences Investment Woes Leave Nation Vulnerable as China Cultivates Future Big Pharma CompetitorsA decade in the making: How functional NAMs are redefining cardiac safety assessment
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ